ELIDEL Cream can help manage mild to moderate eczema.6,7,9

    *PEER (Pediatric Eczema Elective Registry)
  • 10 years of experience
  • 7,924 patients aged 2-17 years
  • 36,126 patient-years

Although rare cases have been reported, a causal relationship between the use of ELIDEL and skin malignancy or lymphoma has not been established. Continuous use of ELIDEL should be avoided, and application should be limited to areas affected by eczema.6

ELIDEL Cream is not indicated for use in children less than 2 years of age.

Always refer to full prescribing information.

Not all patients have been followed for the full duration of the study.
See More


ELIDEL® (pimecrolimus) Cream 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable.



Long-term Safety of Topical Calcineurin Inhibitors Has Not Been Established. Although a causal relationship has not been established, rare cases of malignancy (e.g., skin and lymphoma) have been reported in patients treated with topical calcineurin inhibitors, including ELIDEL Cream.